Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 447

Similar articles for PubMed (Select 15306150)

1.
3.

An automated chromogenic peptide substrate assay for coagulation factor XII.

Jones DW, Gallimore MJ, Winter M.

Blood Coagul Fibrinolysis. 1998 Mar;9(2):183-7.

PMID:
9622217
4.
5.
6.

Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.

Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH; DCCT/EDIC Study Group.

Diabetes. 2003 May;52(5):1215-21.

7.

The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.

Halbmayer WM, Haushofer A, Schön R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M.

Thromb Haemost. 1994 Jan;71(1):68-72.

PMID:
8165648
9.

Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.

Joseph K, Tholanikunnel BG, Kaplan AP.

J Allergy Clin Immunol. 2009 Jul;124(1):143-9. doi: 10.1016/j.jaci.2009.02.006. Epub 2009 Apr 1.

PMID:
19342086
10.

Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.

Fossum S, Hoem NO, Johannesen S, Korpberget M, Nylund E, Sandem S, Briseid K.

Thromb Res. 1994 Jun 1;74(5):477-85.

PMID:
8085248
11.

Factor XII does not initiate prekallikrein activation on endothelial cells.

Røjkjaer R, Hasan AA, Motta G, Schousboe I, Schmaier AH.

Thromb Haemost. 1998 Jul;80(1):74-81.

PMID:
9684789
13.
14.

Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.

Revenko AS, Gao D, Crosby JR, Bhattacharjee G, Zhao C, May C, Gailani D, Monia BP, MacLeod AR.

Blood. 2011 Nov 10;118(19):5302-11. doi: 10.1182/blood-2011-05-355248. Epub 2011 Aug 5.

15.

Studies on components of the contact phase system in patients with advanced gastrointestinal cancer.

Roeise O, Sivertsen S, Ruud TE, Bouma BN, Stadaas JO, Aasen AO.

Cancer. 1990 Mar 15;65(6):1355-9.

PMID:
1689607
17.

Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.

Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page JD, Scott CF, Kappelmayer J, Wyshock EG, Kelly JJ, Colman RW.

Crit Care Med. 1995 Jan;23(1):41-51.

PMID:
7528118
18.

Prekallikrein, HMW-kininogen and factor XII in various disease states.

Deutsch E, Dragosics B, Kopsa H, Mannhalter C, Rainer H.

Thromb Res. 1983 Jul 15;31(2):351-64.

PMID:
6356459
19.

Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.

Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I, Kremer-Hovinga J, Binder BR, Lämmle B.

Atherosclerosis. 2002 Apr;161(2):261-7.

PMID:
11888508
20.

Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.

Shibayama Y, Brunnee T, Kaplan AP, Reddigari S.

Braz J Med Biol Res. 1994 Aug;27(8):1817-28.

PMID:
7749371
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk